| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |